Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 12.10.2026 2 Abdom Radiol (NY) 1 Am J Prev Med 2 Ann Med 1 Antonie Van Leeuwenhoek 1 Aust N Z J Obstet Gynaecol 1 Biochem Biophys Res Commun 1 Biofactors 1 Biomed Phys Eng Express 1 BMC Med 1 BMC Pediatr 1 BMC Public Health 2 BMC Womens Health 1 Br J Community Nurs 1 Cancer Epidemiol 1 Clin Epigenetics 2 Clin Lab 2 Comput Biol Chem 2 Cureus 1 Front Cardiovasc Med 1 Front Immunol 1 Front Med (Lausanne) 4 Front Oncol 3 Front Public Health 1 Front Syst Biol 1 Georgian Med News 1 Histopathology 1 Indian J Med Res 1 Int J Biochem Cell Biol 8 Int J Gynecol Cancer 1 Int J Womens Health 1 Int Urogynecol J 1 J Natl Cancer Inst 1 J Obstet Gynaecol Res 1 J Pain Palliat Care Pharmacother 1 J Public Health Afr 1 JAMA Netw Open 1 JNCI Cancer Spectr 1 Jpn J Radiol 1 Lancet Glob Health 1 Med Oncol 1 Neoplasia 1 NPJ Womens Health 2 Patient Educ Couns 4 Photodiagnosis Photodyn Ther 1 PLoS Biol 1 PLOS Glob Public Health 1 PLoS One 1 Prev Med Rep 1 Public Health 1 Public Health Action 1 Rev Assoc Med Bras (1992) 1 Sante Publique 1 Signal Transduct Target Ther 1 Womens Health (Lond)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Abdom Radiol (NY)

1. HERRERA ORTIZ AF, Del Castillo Herazo V, Olarte LM, Borrero Leon R, et al
   Advanced cervical cancer and its complications: a cross-sectional imaging review.
   Abdom Radiol (NY). 2026 Oct 8. doi: 10.1007/s00261-026-05809.
   PubMed         Abstract available
   
   
2. SHEN H, Jiang Y, Sun Y, Zheng Q, et al
   Peritumoral ultrasound-driven multimodal AI model for predicting lymphovascular space invasion and prognosis in cervical cancer.
   Abdom Radiol (NY). 2026 Oct 8. doi: 10.1007/s00261-026-05804.
   PubMed         Abstract available
   
   

   
   Am J Prev Med

3. OSHIRO CE, Cushing-Haugen KL, Vecchio NJD, Alonge OD, et al
   BMI and Initiation of Cancer Screening: A Closer Look at Differences by Race, Ethnicity, and Sex in a Multicenter Population.
   Am J Prev Med. 2026;71:108434.
   PubMed         Abstract available
   
   

   
   Ann Med

4. WANG Y, Yang H, Gu Q, Wang H, et al
   Repeated remimazolam sedation for interstitial brachytherapy in cervical cancer: a randomized controlled trial.
   Ann Med. 2026;58:2740294.
   PubMed         Abstract available
   
   
5. WANG P, Zhang M, Lai Y, Song T, et al
   Differential diagnostic value of PAX1 and JAM3 methylation for cervical intraepithelial neoplasia between premenopausal and postmenopausal women: a retrospective clinical study in China.
   Ann Med. 2026;58:2722566.
   PubMed         Abstract available
   
   

   
   Antonie Van Leeuwenhoek

6. LI Y, Gu T, Ma L, Yao L, et al
   A pilot evaluation of ChatGPT-4o-assisted hypothesis generation for exploring potential links between fungal biology and cervical cancer.
   Antonie Van Leeuwenhoek. 2026;119:224.
   PubMed         Abstract available
   
   

   
   Aust N Z J Obstet Gynaecol

7. KHAN A, Gullery K, Barber G, Ormandy J, et al
   Impact of Human Papillomavirus Primary Cervical Screening on Referral Rates and Outcomes for People Referred to Colposcopy for Clinical Reasons.
   Aust N Z J Obstet Gynaecol. 2026;66:e70184.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

8. NAVYA VB, Fathima A, Kumar R
   Deciphering the role of microplastics-related molecular signatures in cervical cancer progression: Transcriptomic analysis and diagnostic model development.
   Biochem Biophys Res Commun. 2026;839:154678.
   PubMed         Abstract available
   
   

   
   Biofactors

9. 
   Correction to "HPV Infection Drives CXCL8(+) Neutrophil-Mediated Immune Suppression in Cervical Cancer".
   Biofactors. 2026;52:e70158.
   PubMed        
   
   

   
   Biomed Phys Eng Express

10. PENNEY J, Chytyk-Praznik K
    Patient-Specific Dosimetric Impact of Online Adaptive Radiotherapy for Locally Advanced Cervical Cancer.
    Biomed Phys Eng Express. 2026 Oct 6. doi: 10.1088/2057-1976.
    PubMed         Abstract available
    
    

    
    BMC Med

11. PAN C, Hu S, You T, Gao M, et al
    Potential health impact of therapeutic HPV vaccines in China: a modeling study.
    BMC Med. 2026;24:539.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

12. EVARIST MR, Kibonire RA
    Navigating the divide - demographic and individual predictors of low HPV vaccine uptake in rural Uganda.
    BMC Pediatr. 2026 Jul 3. doi: 10.1186/s12887-026-07143.
    PubMed         Abstract available
    
    

    
    BMC Public Health

13. OGBU CA, Okolie EA, Ume AO, Ajah OF, et al
    HPV knowledge and willingness to receive HPV vaccine among female secondary school students in Ebonyi State, Nigeria: a pre-post evaluation of an educational intervention.
    BMC Public Health. 2026;26:2878.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

14. REN Y, Zhang X, Xu J
    Ectocervical margin involvement is associated with postoperative hrHPV positivity after hysterectomy or residual cervix resection for incompletely excised CIN3: a retrospective study.
    BMC Womens Health. 2026;26:504.
    PubMed         Abstract available
    
    
15. ROODSARABI M, Mirabi P, Farhadi Z, Delavar MA, et al
    The effect of using lubricant for vaginal speculum insertion on the rate of unsatisfactory results of Pap smear: a systematic review and meta-analysis.
    BMC Womens Health. 2026;26:508.
    PubMed         Abstract available
    
    

    
    Br J Community Nurs

16. LEWIS G, Rabie T, Montes MA, Clegg A, et al
    Cost-effectiveness of self-sampling strategies for cervical cancer screening: a commentary.
    Br J Community Nurs. 2026;31:492-498.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol

17. MOU J, Shashikumar S, Shah AK, Chaudhary A, et al
    Advances in isothermal nucleic acid amplification-based HPV assays for cervical cancer screening in low- and middle-income countries: A scoping review.
    Cancer Epidemiol. 2026;105:103244.
    PubMed         Abstract available
    
    

    
    Clin Epigenetics

18. LI M, Zhang X, Zhao X, Wang J, et al
    Preliminary study on PAX1/JAM3 methylation and HPV viral load in CIN3-like squamous cell carcinoma: Are there differences from CIN3 and early invasive carcinoma?
    Clin Epigenetics. 2026;18:178.
    PubMed         Abstract available
    
    

    
    Clin Lab

19. JIN D, Dong Y
    Retrospective Analysis of HPV Infection Status and Genotyping in East China: 2023 - 2024.
    Clin Lab. 2026;72:2187-2193.
    PubMed         Abstract available
    
    
20. ZHENG LF, Qian J, Song YF
    Prognostic Value of MiR-934 and MiR-1260a in Plasma and Early Detection of Metastasis in Patients with Cervical Cancer.
    Clin Lab. 2026;72:2065-2074.
    PubMed         Abstract available
    
    

    
    Comput Biol Chem

21. ZHENG J, Su Z, Zhuo X, Chai H, et al
    Cervical cancer survival analysis by integrating multi-omics data through an adaptive weighted deep neural network.
    Comput Biol Chem. 2026;126.
    PubMed         Abstract available
    
    
22. TABASSUM Z, Hadi K, Sudheer A, Donakonda S, et al
    Bulk and single-cell transcriptomics identify tumor-specific epithelial PSAT1 as a ferroptosis-associated therapeutic target in cervical cancer.
    Comput Biol Chem. 2026;126.
    PubMed         Abstract available
    
    

    
    Cureus

23. RAHMAN Z, Rice J, Edwards L, Sanad E, et al
    Respondent-Reported Acceptability and Tolerability of a Nurse-Assisted, Self-Collected Human Papillomavirus (HPV) Cervical Cancer Screening Model in Adults With Intellectual and Developmental Disabilities: A Preliminary Report.
    Cureus. 2026;18:e117558.
    PubMed         Abstract available
    
    
24. BOUZIANE A, Essadi B, Bekhakh C, Bennani A, et al
    Colonic Angiosarcoma 16 Years After Pelvic Radiotherapy for Cervical Cancer: A Case Report.
    Cureus. 2026;18:e117323.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

25. CAI R, Shen S, Gu C
    Cardio-oncology-relevant programmes in the cervical cancer tumour microenvironment: an exploratory multi-omics and endothelial-cell study.
    Front Cardiovasc Med. 2026;13:1917892.
    PubMed         Abstract available
    
    

    
    Front Immunol

26. SHEN HP, Lee MY, Chao WR, Chen AC, et al
    Immunohistochemical profiling of PD-L1 expression in neuroendocrine carcinoma of the uterine cervix.
    Front Immunol. 2026;17:1933853.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

27. LI X, Xu S, Ren Y, Li M, et al
    Multimodality therapy for stage IB3 cervical cancer with a delayed diagnosis at 21 weeks of gestation: from neoadjuvant chemotherapy to adjuvant chemoradiotherapy-a case report.
    Front Med (Lausanne). 2026;13:1946977.
    PubMed         Abstract available
    
    

    
    Front Oncol

28. WU J, Wang T, Sheng C, Wang W, et al
    Minimal residual disease in cervical cancer: biological persistence, ctHPV DNA-guided surveillance, and recurrence-directed intervention.
    Front Oncol. 2026;16:1938965.
    PubMed         Abstract available
    
    
29. LIU L, Zhang Y, He L, Zhou L, et al
    Menstrual, reproductive, and contraceptive factors associated with cervical cancer in women aged
    Front Oncol. 2026;16:1931698.
    PubMed         Abstract available
    
    
30. XIAO H, Wang F, Wang Y, Liu Y, et al
    Advances in the application of gene methylation detection in cervical cancer screening.
    Front Oncol. 2026;16:1920299.
    PubMed         Abstract available
    
    
31. HUANG L, Zeng W, Pan R, Yu Z, et al
    The construction of a predictive model for postoperative bladder paralysis in patients with cervical cancer based on logistic regression and nomogram.
    Front Oncol. 2026;16:1877348.
    PubMed         Abstract available
    
    

    
    Front Public Health

32. WU M, Shen L, Jiang N, Wang H, et al
    Perceived community cervical cancer prevention support and cervical cancer screening utilization among women in Shenzhen, China: a cross-sectional study.
    Front Public Health. 2026;14:1964812.
    PubMed         Abstract available
    
    
33. BALASUBRAMANI L, Madhivanan P, Anand M, Gupta M, et al
    From evidence to implementation: a policy and health systems roadmap for cervical cancer elimination in India.
    Front Public Health. 2026;14:1906243.
    PubMed         Abstract available
    
    
34. NEZE-SEBAKUNZI J, Doro Altan AM, Ceffa S, Guidotti G, et al
    Prevalence, high-risk HPV type profile, and factors associated with high-risk HPV infection among women living with HIV in Kinshasa, Democratic Republic of the Congo.
    Front Public Health. 2026;14:1914799.
    PubMed         Abstract available
    
    

    
    Front Syst Biol

35. SINGH S, Srivastava M, Uppada P, Ameta D, et al
    The causal integration ladder: a multilevel evidence framework for therapeutic target evaluation in cervical cancer.
    Front Syst Biol. 2026;6:1874355.
    PubMed         Abstract available
    
    

    
    Georgian Med News

36. KAMASHIDZE K, Beruchashvili T, Nakashidze I, Ahmad S, et al
    BRIDGING THE COVERAGE-PARTICIPATION GAP: BEHAVIORAL DETERMINANTS OF CERVICAL CANCER SCREENING AMONG WOMEN IN ADJARA, GEORGIA.
    Georgian Med News. 2026;.
    PubMed         Abstract available
    
    

    
    Histopathology

37. PAUDICE M, Parrella V, Scaglione G
    Endocervical gastric-type AIS: a rare histologic finding that further supports the hypothesis of a pyloric-type metaplastic origin.
    Histopathology. 2026;89:892-894.
    PubMed         Abstract available
    
    

    
    Indian J Med Res

38. SHERPA ML, Lucksom PG, Sherpa M, Pradhan A, et al
    Self-collected cervical samples for detection of high-risk human papillomavirus: A community outreach approach in a remote region.
    Indian J Med Res. 2026;164:559-565.
    PubMed         Abstract available
    
    

    
    Int J Biochem Cell Biol

39. WANG F, Shan S, Huo Y, Xie Z, et al
    Corrigendum to "MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer" [Int. J. Biochem. Cell Biol. 99 (2018) 91-99].
    Int J Biochem Cell Biol. 2026 Oct 7:107038. doi: 10.1016/j.biocel.2026.107038.
    PubMed        
    
    

    
    Int J Gynecol Cancer

40. PEDRAO PG, Hirai WY, Losano GP, Pascoal GN, et al
    Relative diagnostic performance and feasibility of filter paper for storing self-collected vaginal samples for human papillomavirus testing in Brazil: A cross-sectional study.
    Int J Gynecol Cancer. 2026;36:104975.
    PubMed         Abstract available
    
    
41. LOPEZ-ALZA LC, Mejia-Perez DL, Amaya-Guio J, Orjuela-Canon AD, et al
    Predicting high-grade lesions and cervical cancer with supervised machine learning algorithms.
    Int J Gynecol Cancer. 2026 Sep 1:104997. doi: 10.1016/j.ijgc.2026.104997.
    PubMed         Abstract available
    
    
42. SHAFFI AF, Omwodo KA, Mburu A, Mutengo R, et al
    Financial toxicity as a structural barrier to cervical cancer treatment in Sub-Saharan Africa.
    Int J Gynecol Cancer. 2026;36:104902.
    PubMed         Abstract available
    
    
43. VIVEROS-CARRENO D, Mora-Soto N, Beshar I, Cruz C, et al
    Mapping country-level structural capacity constraints in brachytherapy infrastructure for locally advanced cervical cancer in the Americas: a cross-sectional study.
    Int J Gynecol Cancer. 2026;36:104863.
    PubMed         Abstract available
    
    
44. NOLL F, Heredia F, Alvarenga-Bezerra V, Accioly Rosa A, et al
    Radiotherapy and brachytherapy capacity, treatment timelines, and barriers to guideline-concordant curative care for cervical cancer in Latin America: the LATAM-CxRT study.
    Int J Gynecol Cancer. 2026;36:104980.
    PubMed         Abstract available
    
    
45. POSSATI-RESENDE JC, de Araujo Batistao HK, Biot ST, Hirai WY, et al
    Cervical cancer prevention in motion: national impact of the Barretos Cancer Hospital model.
    Int J Gynecol Cancer. 2026;36:104968.
    PubMed         Abstract available
    
    
46. CUELLO MA, Pino MD, van den Brule AJC, Joura EA, et al
    Operationalizing cervical cancer elimination: a health-system archetype framework for implementation.
    Int J Gynecol Cancer. 2026;36:104966.
    PubMed         Abstract available
    
    
47. MORETTI-MARQUES R, Elizabeth de Moura V, Franca IB, Ernesto de Cillo P, et al
    Radical trachelectomy in Brazil: a multi-institutional review on fertility preservation and oncologic outcomes.
    Int J Gynecol Cancer. 2026;36:104978.
    PubMed         Abstract available
    
    

    
    Int J Womens Health

48. KAZINDU TM, Lurhangire E, Mulume AB, Hermans MP, et al
    Cervical Cancer Knowledge, Attitudes, and Practices Among Informal Sector Women: Prevention Challenges in Eastern Democratic Republic of the Congo.
    Int J Womens Health. 2026;18:646534.
    PubMed         Abstract available
    
    

    
    Int Urogynecol J

49. OZUM G, Guraslan H, Tassolak H, Deniz L, et al
    Postoperative Outcomes of the Manchester-Fothergill Procedure: Cervical Cytology Adequacy and Transformation Zone Accessibility: A Prospective Cohort Study.
    Int Urogynecol J. 2026;37:3095-3104.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

50. TSEGAYE AT, Kreimer AR, Shing JZ, Clarke MA, et al
    Hysterectomy-corrected incidence of cervical cancer among women with HIV in the United States, 2001-2019.
    J Natl Cancer Inst. 2026 Oct 3:djag352. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

51. KOOHACHAISKUN N, Atjimakul T, Peeyananjarassri K, Klangsin S, et al
    Effects of Estriol-Lactobacilli Combination Versus Polycarbophil-Based Vaginal Moisturizer on Post-Radiation Vaginitis in Women With Cervical Cancer: A Randomized Controlled Trial.
    J Obstet Gynaecol Res. 2026;52:e70525.
    PubMed         Abstract available
    
    

    
    J Pain Palliat Care Pharmacother

52. ARAI T
    Three Years of Bidirectional, Home-Based Opioid Route Management in Advanced Cervical Cancer with Coexisting Causes of Route Failure: A Case Report.
    J Pain Palliat Care Pharmacother. 2026.
    PubMed         Abstract available
    
    

    
    J Public Health Afr

53. DIONGUE FB, Ndiaye I, Sougou NM, Bassoum O, et al
    Health facility-related barriers associated with cervical cancer screenings in the health districts of Dakar and Kedougou (2023, Senegal).
    J Public Health Afr. 2026;17:1879.
    PubMed         Abstract available
    
    

    
    JAMA Netw Open

54. HARPER DM, Lin PJ, Young AP, Rehkopf DH, et al
    College Attendance, Physical Disability, and Cervical Cancer Screening.
    JAMA Netw Open. 2026;9:e2637495.
    PubMed        
    
    

    
    JNCI Cancer Spectr

55. MIRZAEV UK, Juraev JR, Sharipova IP, Islomov ST, et al
    Population?based registry analysis of cervical cancer trends in Tashkent Uzbekistan 2014-2024.
    JNCI Cancer Spectr. 2026 Oct 9:pkag107. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Jpn J Radiol

56. ITO K, Nakajima Y, Ogawa H, Furusawa A, et al
    Long-term results of stereotactic body radiotherapy boost in patients with cervical cancer considered unsuitable for intracavitary brachytherapy.
    Jpn J Radiol. 2026 Oct 3. doi: 10.1007/s11604-026-02089.
    PubMed         Abstract available
    
    

    
    Lancet Glob Health

57. THE EDITORS OF THE LANCET GLOB
    Expression of concern-Effect of Brazil's national human papillomavirus vaccination programme on the incidence of cervical cancer and cervical intraepithelial neoplasia grade 3 in women aged 20-24 years: a population-based study.
    Lancet Glob Health. 2026 Oct 7:104113. doi: 10.1016/j.langlo.2026.104113.
    PubMed        
    
    

    
    Med Oncol

58. KUMAGAI K, Suzuki Y, Kitahara K, Chiba A, et al
    Host chromatin architecture in HPV-driven cervical cancer: molecular mechanisms and therapeutic resistance.
    Med Oncol. 2026;43:324.
    PubMed         Abstract available
    
    

    
    Neoplasia

59. LU L, Wei X, Liu S, Lei S, et al
    RSPO1-LGR4 axis drives cervical cancer progression via activation of the EGFR/Src/ERK/AKT signaling pathway.
    Neoplasia. 2026;82:101374.
    PubMed         Abstract available
    
    

    
    NPJ Womens Health

60. ELLER K, Skerrett E, Huchko MJ, Kerner N, et al
    The Callascope: A portable, user-friendly, speculum-free device for diagnostic imaging of cervical cancer precursor lesions.
    NPJ Womens Health. 2026;4:32.
    PubMed         Abstract available
    
    

    
    Patient Educ Couns

61. HUBER L, Bootsma TI, Jean K, van Iersel CA, et al
    Awareness, barriers, experiences and preferences regarding cervical and breast cancer screening among transgender and non-binary individuals.
    Patient Educ Couns. 2026;153:109860.
    PubMed         Abstract available
    
    
62. TOLESSA A, Winer RL, Barsness CB, Desai J, et al
    Developing personas and empathy maps to understand perceptions of HPV self-sampling in the Somali American Community.
    Patient Educ Couns. 2026;153:109855.
    PubMed         Abstract available
    
    

    
    Photodiagnosis Photodyn Ther

63. KONG D, Su Y, Gao C, Li L, et al
    The efficacy comparison of laser ablation combined with photodynamic therapy versus LEEP for women with CIN2/3 of childbearing age: a non-randomized case-control study.
    Photodiagnosis Photodyn Ther. 2026;61:105577.
    PubMed         Abstract available
    
    
64. LIU X, Zhang T, Zou D, Zhang J, et al
    Efficacy and safety of 5-ALA-PDT in patients with persistent HR-HPV infection and lower genital tract low-grade intraepithelial lesions after cervical conization.
    Photodiagnosis Photodyn Ther. 2026;61:105576.
    PubMed         Abstract available
    
    
65. KONG D, Gao C, Li L, Chen R, et al
    The efficacy of laser ablation combined with photodynamic therapy vs PDT for CIN2/3 in reproductive women: a prospective case-control study.
    Photodiagnosis Photodyn Ther. 2026;61:105557.
    PubMed         Abstract available
    
    
66. LU L, Xu C, Chen R, Lv W, et al
    A comparative study of treatment of persistent cervical low-grade squamous intraepithelial lesions with HPV16/18 infection.
    Photodiagnosis Photodyn Ther. 2026;61:105631.
    PubMed         Abstract available
    
    

    
    PLoS Biol

67. PAN T, Zhuang X, Zhang Y, Guo J, et al
    Integrated multi-omics analysis reveals the molecular landscape and therapeutic strategies in Chinese cervical cancer patients.
    PLoS Biol. 2026;24:e3004029.
    PubMed         Abstract available
    
    

    
    PLOS Glob Public Health

68. SECK FB, Awadalla S, Diongue FB, Ndiaye I, et al
    Impact of cervical cancer-related stigma on screening uptake in Dakar and Kedougou, Senegal: A context-specific stigma index.
    PLOS Glob Public Health. 2026;6:e0006187.
    PubMed         Abstract available
    
    

    
    PLoS One

69. HENDRICKX M, Kerckhaert LA, Willems S, Crutzen R, et al
    Untimely follow-up after cervical cancer screening: A qualitative study among healthcare providers in Flanders (Belgium).
    PLoS One. 2026;21:e0359860.
    PubMed         Abstract available
    
    

    
    Prev Med Rep

70. JENKINS WD, Choudhary V, Miller KW, Bhandari P, et al
    Urgent need for cervical cancer screening emphasis and engagement strategies among rural LGBTQ+ individuals.
    Prev Med Rep. 2026;71:103647.
    PubMed         Abstract available
    
    

    
    Public Health

71. CREAGH NS, Nightingale C, Brotherton JM, Hocking JS, et al
    The impact of the universal choice of self-collection on cervical screening participation in Australia's National Cervical Screening Program: A population-based interrupted time series analysis.
    Public Health. 2026;259:106474.
    PubMed         Abstract available
    
    

    
    Public Health Action

72. YADAV P, Alwani AA, Harries AD, Deshmukh PR, et al
    Leveraging sexually transmitted infection clinics for cervical cancer screening: evidence from India.
    Public Health Action. 2026;16:202-208.
    PubMed         Abstract available
    
    

    
    Rev Assoc Med Bras (1992)

73. YILDIZ P, Topcu G, Aydin G, Uzun A, et al
    Retrospective study of inflammatory markers in high-grade cervical lesions.
    Rev Assoc Med Bras (1992). 2026;72:e20260706.
    PubMed         Abstract available
    
    

    
    Sante Publique

74. RAIAH M
    [Is the cervical cancer screening program in Algeria effective using the Pap smear test?].
    Sante Publique. 2026;38:309-315.
    PubMed         Abstract available
    
    

    
    Signal Transduct Target Ther

75. DONG B, Wang Y, Qin Y, Chen L, et al
    Multi-omics profiling reveals homologous recombination repair hyperactivation as a therapeutic vulnerability in neuroendocrine cervical carcinoma.
    Signal Transduct Target Ther. 2026;11:424.
    PubMed         Abstract available
    
    

    
    Womens Health (Lond)

76. DEVOTTA K, Lofters A, Sayani A, Shapiro GK, et al
    Integrating behavioural science into HPV self-sampling and cervical cancer elimination strategies.
    Womens Health (Lond). 2026;22:17455057261484755.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum